Quality and performance improvement for mental healthcare in Japan

Current Opinion in Psychiatry

Volumn 22, Issue 6, 2009, Pages 619-622

  Ito, Hiroto ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

Mental health; Performance; Polypharmacy; Quality improvement; Seclusion and restraint

Indexed keywords

NEUROLEPTIC AGENT;

GOVERNMENT; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; JAPAN; LAW; MENTAL DISEASE; MENTAL HEALTH CARE; POLYPHARMACY; PRESCRIPTION; REVIEW;

DELIVERY OF HEALTH CARE; HUMANS; JAPAN; MENTAL DISORDERS; MENTAL HEALTH SERVICES; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY ASSURANCE, HEALTH CARE; QUALITY OF HEALTH CARE;

EID: 70350154548     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e3283318ea5     Document Type: Review

References (40)

1. World Health Organization. Quality improvement for mental health: mental health policy and service guidance package. Geneva: World Health Organization; 2003.
2. Pincus HA, Page AEK, Druss B, et al. Can psychiatry cross the quality chasm? Improving the quality of healthcare for mental and substance use conditions. Am J Psychiatry 2007; 164:712-719.
3. Nakatani Y. Psychiatry and the law in Japan: history and current topics. Int J Law Psychiatry 2000; 23:589-604.
4. Ito H, Sederer LI. Mental health services reform in Japan. Harv Rev Psychiatry 1999; 7:208-215.
5. Yoshikawa K, Taylor P, Yamagami A, et al. Violent recidivism among mentally disordered offenders in Japan. Crim Behav Ment Health 2007; 17:137-151.
6. Satsumi Y, Inada T, Yamauchi T. Criminal offenses among discharged mentally ill individuals. Determinants of the duration from discharge and absence of diagnostic specificity. Int J Law Psychiatry 1998; 21:197-207.
7. Kuno E, Asukai N. Efforts toward building a community-based mental health system in Japan. Int J Law Psychiatry 2000; 23:361-373.
8. Tsuchiya KJ, Takei N. Focus on psychiatry in Japan. Br J Psychiatry 2004; 184:88-92.
9. Yoshikawa K, Taylor PJ. Editorial: new forensic mental health law in Japan. Crim Behav Ment Health 2003; 13:225-228.
10. Weisstub DN, Carney T. Forensic mental health law reform in Japan: from criminal warehousing to broad-spectrum specialist. Int J Law Psychiatry 2006; 29:86-100.
11. Tseng WS, Ebata K, Kim KI, et al. Mental health in Asia: social improvements and challenges. Int J Soc Psychiatry 2001; 47:8-23.
12. Government of Japan. The comprehensive suicide prevention initiative. Tokyo: Government in Japan; 2007.
13. McCurry J. Japan to rethink suicide-prevention policies. Lancet 2008; 371:2071.
14. Japan Minister of Health, Labour, and Welfare. Report on a reform vision of mental healthcare system [in Japanese, English version is available at http:// www.ncnp.go.jp/nimh/keikaku/vision/e7.html]. Tokyo: Japan Ministry of Health, Labour, and Welfare; 2004.
15. Hamid H, Abanilla K, Bautaa B, Huanga KY. Evaluating the WHO assessment instrument for mental health systems by comparing mental health policies in four countries. Bull World Health Organ 2008; 86:467-473.
16. Takeshima T. Mental health and welfare [in Japanese]. Tokyo: Report for Ministry of Health, Labour and Welfare; 2009.
17. Ito H, Iwasaki S, Nakano Y, et al. Direction of quality improvement activities of healthcare organizations in Japan. Int J Qual Healthcare 1998; 10:361-363.
18. Hirose M, Imanaka Y, Ishizaki T, Evans E. How can we improve the quality of healthcare in Japan? Learning from JCQHC hospital accreditation. Health Policy 2003; 66:29-49.
19. Ono Y, Satsumi Y, Kim Y, et al. Schizophrenia: is it time to replace the term? Psychiatry Clin Neurosci 1999; 53:335-341.
20. Kim Y, Berrios GE. Impact of the term schizophrenia on the culture of ideograph: the Japanese experience. Schizophr Bull 2001; 27:181-185.
21. Kim Y, Committee of Renaming the Term Schizophrenia of the Japanese Society of Pyschiatry and Neurology. Renaming the term schizophrenia in Japan. Lancet 2002; 360:879.
22. Joint Commission. Specifications manual for national hospital inpatient quality measures-hospital-based inpatient psychiatric services core measure set (version 2.0); 2008.
23. Sim K, Su A, Leong JY, et al. High dose antipsychotic use in schizophrenia: findings of the REAP (Research on East Asia Psychotropic Prescriptions) study. Pharmacopsychiatry 2004; 37:1-6.
24. Ito H, Koyama A, Higuchi T. Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription. Br J Psychiatry 2005; 187:243-247.
25. Sim K, Su HC, Fujii S, et al. High-dose antipsychotic use in schizophrenia: a comparison between the 2001 and 2004 research of East Asia Psychotropic Prescription (REAP) studies. Br J Clin Pharmacol 2008; 67:110-117.
26. Japanese Association for Emergency Psychiatry. Research on quality assurance of emergency psychiatric units [in Japanese]. Tokyo: Report for Ministry of Health, Labour and Welfare; 2009.
27. Noda T, Sugiyama N, Kawabata T, et al. Development of quality indicators to monitor seclusion and restraint of patients on the basis of official records maintained at psychiatric hospitals [in Japanese]. Seishin Igaku (in press).
28. Oshima I, Cho N, Takahashi K. Effective components of a nationwide case management program in Japan for individuals with severe mental illness. Community Ment Health J 2004; 40:525-537.
29. Oshima I, Mino Y, Inomata Y. Institutionalisation and schizophrenia in Japan: social environments and negative symptoms - nationwide survey of inpatients. Br J Psychiatry 2003; 183:50-56.
30. Oshima I, Kuno E. Living arrangements of individuals with schizophrenia in Japan: impact of community-based mental health services. Int J Soc Psychiatry 2006; 52:55-64.
31. Mizuno M, Sakuma K, Ryu Y, et al. The Sasagawa project: a model for deinstitutionalisation in Japan. Keio J Med 2005; 54:95-101.
32. Ito J. Future of assertive community treatment in Japan. Psychiatria et Neurologia Japonica 2009; 111:313-318. [in Japanese].
33. Horiuchi K, Nisihio M, Oshima I, et al. The quality of life among persons with severe mental illness enrolled in an assertive community treatment program in Japan: 1-year follow-up and analyses. Clin Pract Epidemiol Ment Health 2006; 2:18.
34. Shinfuku N. Mental health services in Asia: international perspective and challenge for the coming years. Psychiatry Clin Neurosci 1998; 52:269-274.
35. Nawata S, Yamauchi K, Ikegami N. Do staffing levels determine outcome in psychiatric inpatient care? Factors related to the ratio of period hospitalized in Japan. Psychiatry Clin Neurosci 2006; 60:709-717.
36. Someya T, Suzuki Y, Sham PC, Tang SW. Forecasting the number of inpatients with schizophrenia. Psychiatry Clin Neurosci 2004; 58:573-578.
37. Arai Y, Ikegami N. Healthcare systems in transition II. Japan, Part I. An overview of the Japanese healthcare systems. J Public Health Med 1998; 20:29-33.
38. Tajima O. Mental healthcare in Japan: recognition and treatment of depression and anxiety disorders. J Clin Psychiatry 2001; 62 (Suppl):39-44.
39. Slade M, McCrone P, Kuipers E, et al. Use of standardized outcome measures in adult mental health services. Br J Psychiatry 2006; 189:330-336.
40. Hübner-Liebermann B, Spiessl H, Iwai K, Cording C. Treatment of schizophrenia: implications derived from an intercultural hospital comparison between Germany and Japan. Int J Soc Psychiatry 2005; 51:83-96.